← Eichor
Condition: Adrenal Gland Neoplasm Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Adrenal Gland Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CRISAL Study:Cancer Risk In Secreting Adrenal Lesions
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT06520111
An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143
Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex Carcinoma
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07335679
Registry of Endocrine Tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube)
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT03410394
A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06041516
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01005654
Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Phase 2 · 1 location(s) · Mayo Clinic · NCT07104812
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT00588068
A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymp
Phase N/A · 2 location(s) · University Children's Hospital Basel · NCT06861530
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT03374215
Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)
Phase 2 · 1 location(s) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di · NCT05913427
PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism
NA · 2 location(s) · Seoul National University Hospital · NCT07027254
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06066333
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06487481
Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions
NA · 1 location(s) · Centre Georges Francois Leclerc · NCT05783908
R.E.C.K vs Exparel in Robotic Nephrectomy
Phase 3 · 1 location(s) · Wake Forest University Health Sciences · NCT07092566
Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carci
Phase 2 · 1 location(s) · West China Hospital · NCT06831175
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Phase N/A · 50 location(s) · Zhujiang Hospital · NCT05638269
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Phase 1/Phase 2 · 1 location(s) · Crinetics Pharmaceuticals Inc. · NCT05804669
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
Phase N/A · 10 location(s) · Latin American Cooperative Oncology Group · NCT06279442
Multifaceted Comparison of Ultrasound-guided Ablation and Laparoscopic Adrenalectomy for Aldosterone-producing Adenoma
Phase N/A · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT05991856
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
Phase 2 · 22 location(s) · UNICANCER · NCT06333314
Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268
REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
NA · 1 location(s) · Meyer Children's Hospital IRCCS · NCT07412782
Ivonescimab in the Treatment of Multiple Advanced Tumors
Phase 2 · 1 location(s) · Fudan University · NCT06683846
Stereotactic Magnetic Resonance Guided Radiation Therapy
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT04115254
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Color
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05286814
Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unres
Phase 2 · 2 location(s) · Emory University · NCT06006013
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168
Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT04127552
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.